Prospective and retrospective incidence cohort studies have been consistent in identifying an increased mortality in patients with epilepsy, although risk ratios vary considerably. Standardized mortality ratios in these populations range from 1.6 to 5.3, but they tend to be higher in studies in selected populations.
Introduction
Many epidemiological studies have established beyond doubt that patients with epilepsy carry a significantly higher mortality rate than the general population. This has been shown in large population-based cohort incidence studies as well as in more selected populations [1,2,3 . . ].
The epidemiological approach to mortality in epilepsy is difficult. It depends on the accuracy of information concerning the cause of death and the methods used [3 . . ]. On these grounds, comparisons between studies are problematical. Recent studies have been based on large cohorts, which is the best approach. Some recent studies have been carried out on: patients who have undergone epilepsy surgery; mortality rates in status epilepticus (SE); suicide; and sudden unexplained death in epilepsy (SUDEP).
Definitions
Some definitions are important for a better understanding of the different rates used in epidemiology of mortality.
Case fatality
Case fatality refers to the number of deaths divided by the number of patients with the disease in the study population. It is influenced by the distribution of prognostic factors and by differences in medical care.
Mortality rate
The mortality rate is the number of deaths that occur in a defined population in a specific time divided by the person-years at risk in that population. It is influenced by the incidence of epilepsy in a population, the case fatality and the age distribution of the population.
Standardized mortality ratio
The standardized mortality ratio (SMR) is the ratio of the observed number of deaths in a population with epilepsy to that expected, based on the age and sexspecific mortality rates in a reference population. It may be difficult to compare SMRs between studies because the measure depends on the mortality rate in the reference population, which may vary between studies.
Proportionate mortality ratio
The proportionate mortality ratio is the proportion of deaths as a result of specific causes among cohorts of people with epilepsy. It compares the relative contribution of different causes with the overall mortality in a specific population.
Overall mortality
Shackelton et al. [4 . . ] investigated the extent and causes of differences in mortality found in studies on mortality in epilepsy based on a quantitative review of the literature. Twenty-one studies, reported in 23 articles (but only 19 were included in the study) were analysed for a meta-analysis. SMRs ranged from 1.3 to 9.3 (0.3-3.1 in community studies and 1.9-5.1 in institutionalized populations). The mortality risk is highly dependent on source populations, explaining half of the variance of the estimates.
Prospective and retrospective incidence cohort studies have been consistent in identifying an increased mortality rate in patients with epilepsy. SMRs in these populations range from 1.6 to 5.3 in children and adult populations [5] [6] [7] [8] [9] [10] [11] 12 . . ] ( Table 1 ). The SMR is more important in studies in children and in some selected populations [13,14,15 . ,16,17 . . ,18,19,20 . . ] ( Table 2) . Higher SMRs have been reported in French and Swiss studies [9, 10] because they included provoked and unprovoked seizures. In the Swiss study [10] , HIV infection in the 1980s has increased the incidence of unprovoked seizures in relation to a progressive condition such as central nervous system infections and lymphoma (period effect).
A large cohort study of patients over 15 years old (9061 patients; 53 520 person-years) who were admitted and discharged from any hospital in Stockholm, Sweden, with a diagnosis of epilepsy during the years 1980-1989, was followed until the end of 1992 [13] . An SMR of 3.6 [95% confidence interval (CI) 3.5-3.7] was estimated. This high mortality ratio and the narrow intervals could be explained by selection bias (hospital admission), the diagnosis assessment of epilepsy (the review of medical records of a sample of these cases revealed that only 80% fulfilled the criteria for epilepsy), and the accuracy of reporting the cause of death, which was based, in the study, only on death certificates. In a retrospective study of the survival status of outpatients followed in a Dutch epilepsy centre over a mean duration of 28 years (404 deaths; 38 665 person-years) [14] the SMR was 3.2 (95% CI 2.9-3.5). The SMR was markedly high in the younger age groups (13 in the 0-8 years group) and in the first years after diagnosis. It decreased in the older age group (cohort effect).
Very few studies of death in epilepsy have included substantial numbers of children with a long-term followup [12 . . ,21] . The Nova Scotia study [12 . . ] is a population-based cohort study. Twenty-six out of 686 children who developed epilepsy during 1977-1985 died [11] , respectively.
Only one study was carried out in a developing country [17 . . ] . A total of 412 newly diagnosed epilepsy patients were selected and followed-up from six main hospitals in Ecuador. During the follow-up period seven patients died. The SMR was 6.3. One patient had definite SUDEP (14.3%), two had probable SUDEP (28.6%), one had aspiration pneumonia (14.3%), two had seizurerelated death (28.6%), and one had a stroke (14.3%).
There was some selection bias in the study because of the assessment and accuracy of the cause of death. There was a high percentage of loss of patients in the cohort; therefore, it is possible that mortality may have been even higher. An autopsy was performed on only one patient. The absolute number of SUDEP cases in this cohort was small. It does not allow internal comparisons.
Cause-related deaths
Using person-time as the unit of the study, Strauss et al. [22 . . ] reported one of the largest population-based studies of mortality in patients with remote symptomatic epilepsy, with 46 807 person-years of data. The authors found that in patients with a history of remote symptomatic epilepsy, both the frequency and type of seizures affected mortality. SMR was estimated at 2.4 (1.9-3.0) in patients who presented with seizures in the past year, and especially in those with a generalized tonic-clonic seizure event (2.9; 2.4-3.4) -even more than those with SE in the past year (3.7; 2.5-5.4). However, the population was quite heterogeneous: the prevalence of epilepsy ranged from 7% (chromosomal abnormalities) to 28% (traumatic brain injury). Therefore, the results could not be consistent to all persons with epilepsy. The study did not address cause-specific mortality rates.
Surgery
A few studies have addressed the mortality rate in patients after epilepsy surgery [18, 19, 23] . In the UK study [18] , 20 deaths occurred in a cohort of 305 consecutive patients who had temporal lobe epilepsy (TLE) surgery over a 20-year period. The estimated SMR was 4.5 (95% CI 3.2-6.6). Six deaths were SUDEP (one per 455 person-years). The mortality in patients who had right-sided resections for mesial temporal sclerosis was considerably elevated, with a SMR of 32 (95% CI 24.7-40.5). These patients had significantly lower remission rates and more severe or convulsive seizures than left-sided patients. In the US study [19] , 11 out of 215 patients died (SMR 5.27). Three out of 148 were seizure free compared with eight out of 67 with persistent seizures. There was no significant difference in the late mortality rate between patients undergoing right versus left-sided resections (5.7 versus 4.5%). The main factors contributing to the late mortality rate were the persistence of seizures after surgery and the long duration of epilepsy before surgery [24] .
In a large population-based study [20 . . ] comparing the incidence of SMR and SUDEP in patients who underwent surgery and those whose presurgical evaluation started, the SMR for all causes of death in surgery patients was 4.9 (95% CI 2.7-8.3) versus 7.9 (95% CI 2.6-18.4) in non-surgery patients. The incidence of SUDEP was 2.5 per 1000 versus 6.3. SMR and SUDEP were higher in right-sided TLE. These results confirmed that the influence of surgery on mortality cannot be ruled out.
Status epilepticus
Despite recent improvements in diagnosis and therapeutic management, SE remains associated with significant mortality [25 . . , [26] [27] [28] [29] [30] [31] [32] [33] [34] (Table 3 ). In prospective population-based studies the case fatality rate reached 22%. In a recent study performed in Sao Paulo, Brazil [35] , the case fatality rate was 21.2%, with the percentage of deaths in the elderly greater than in other age groups, and the majority of deaths were in relation to the cause of SE, and were more often observed in patients with no previous history of epilepsy. Using the hospital discharge database of the state of California, USA, Wu et al. [36 . ] reported a decline in the incidence of SE requiring hospitalization, which fell by 42% between the years 1991 and 1998 from 8.5 to 4.9. The case fatality rate was 10.7%, and was higher in patients who carried cerebral anoxia, central nervous system infections or stroke, but in multivariate analysis increasing age was the only significant predictor [36 . ]. In a recent Italian study [37] the 30-day case fatality rate was 39%, and indirect evidence suggested that early patient management could influence the outcome of SE.
In some studies, the incidence and mortality of SE has increased in the past 30 years as a result of the inclusion of myoclonic SE after cardiac arrest [26] . This is problematical as these patients are too often considered to have subtle SE without careful electroencephalogram data, and because the situation often leads to a limitation of the treatment [30] .
Suicide
Patients with epilepsy are considered to be at higher risk of committing suicide than the general population [38,39 . . ]. However, the rates vary from zero to 25%. Methodological problems are a serious drawback when studying suicide in epilepsy because reports are based on small samples from different populations, highly selected groups of patients, or different methods of analysis are used. In the UK National General Practice Study of Epileps, with a total of 11 400 patient-years,
Cockerell et al. [40] did not show any excess of suicide.
Another study reported only five suicides in a 12-year period in 10 739 patients with epilepsy seen in a US centre from 1987 to 1999 [41] . In patients with surgically treated TLE, the risk seemed to be increased [18, 19] .
Only two studies based on large cohorts from the Chalfont Centre for Epilepsy and from the Stockholm County inpatient register estimated SMRs of 5.4 and 3.5, respectively [39 . . ,42] . In the last study cases and controls came from the same epilepsy cohort (6880 patients). Twenty-six suicides and 23 cases of suspected but not confirmed suicide and 171 controls were included in the study. Psychiatric illness was associated with a ninefold increase in the risk of suicide and an increase of 10-fold with the use of antipsychotic drugs. However, the relative risk associated with the intake of antipsychotic drugs was 4 after adjustment for psychiatric illness and alcohol abuse. An early onset of epilepsy, particularly in adolescence, was the only epilepsy-related factor strongly related to the increased risk of suicide. No association was found between the duration of epilepsy for any particular antiepileptic drug (AED), the type of epilepsy or the localization of the epileptogenic focus. Several hypotheses have been put forward to explain the excess of suicide rates in patients with epilepsy, psychiatric co-morbidity and especially depression, as well as iatrogenic factors and the results of psychossocial stressors generated by a long-standing handicap being the most common risks. In a recent case-control Japanese study [43] suicide was reported in 14% of the cases with a statistical relationship between TLE and ictal or interictal epileptic manifestations, rather than the consequences of long-standing handicap.
Sudden unexplained death SUDEP is more frequent in individuals with epilepsy than in the general population [44] , and is generally considered to be the most frequent epilepsy-related death. The incidence of SUDEP ranges from one per 100 epilepsy surgery candidates to one per 1000 in prevalent cases and 3.5 per 10 000 in incidence studies [45, 46] .
In spite of many clinical and experimental studies, little is known about the risk factors for SUDEP. Two recent studies have elaborated on this topic. In a case-control study, Nilsson et al. [47] reported 57 SUDEP cases, of whom 91% had undergone an autopsy (minimum annual SUDEP incidence 1.5/1000). The frequency of seizures was the factor most strongly associated with the risk of SUDEP, and was more pronounced in men (10.16 in patients with more than 50 seizures per year compared with those with up to two seizures per year). The number of AEDs taken (more than three AEDs) is also related to an increased risk of SUDEP. Frequent changes of AED dosages compared with no change during the past year were associated with a sixfold increased relative risk, especially in women. A slight risk with the use of psychopharmacological drugs was also noted. Among men, the relative risk was 18-fold, and increased with the onset of epilepsy in childhood or early adolescence [47] .
In the US study [48] , 4578 patients from three epilepsy centres were prospectively followed for 16 463 patientyears, but only half of the cases underwent an autopsy. The incidence of SUDEP was 1.21 per 1000 patientyears, and was higher in women (1.45 versus 0.98). SUDEP accounted for 18% of the deaths in this prevalence cohort. It is not known whether there is a progressive risk of SUDEP with increased seizure frequency; in contrast, the number of tonic-clonic seizures per year was associated with a strong risk of SUDEP, whereas the frequency of all seizures was no longer a risk factor. This finding supports the hypothesis that tonic-clonic seizures are an important proximate cause of SUDEP. A long duration of epilepsy [430 years; odds ratio (OR) 13.9] and mental retardation were also risk factors for SUDEP even after adjustment for seizure frequency (OR 4.6). The number of AEDs used is also a risk factor after adjusting for the number of all seizures (OR 3.8) and the number of tonic-clonic seizures (OR 3), but no specific AED seemed to be associated with a higher risk of SUDEP. In contrast, noncompliance and psychotropic drugs were not associated with an increased risk of SUDEP in this cohort [48] . In the last study the only risk factor was the young age of the patients [49 . ].
There is clinical and experimental evidence to support the theory that SUDEP is a recent seizure-mediated event. Thom 
Conclusion
Mortality is an important part of the burden of epilepsy.
The results of numerous studies are consistent with an increased risk in all patients with epilepsy. However, epilepsy itself is rarely the cause of death. The influence of seizures opposed to the effect of underlying conditions on mortality (in SE and suicide) must be developed. The role of therapeutic interventions (AEDs and surgery) and seizure control on mortality must be explored. In some situations, the increased risk of death could be preventable by a better definition of populations at increased risk (suicide and SUDEP).
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